Perindopril Amlodipine for the Treatment of Hypertension
Phase 3
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2015-09-28
- Lead Sponsor
- Symplmed Pharmaceuticals LLC
- Target Recruit Count
- 837
- Registration Number
- NCT01556997
© Copyright 2025. All Rights Reserved by MedPath